RTTNews - Canadian stocks could extend its slump on Tuesday morning with markets in the U.S. and Europe seeing red.

Biovail (BVF.TO) may come under pressure after reporting it failed to reach its primary end point in a Phase III study for pimavanserin, its drug to treat Parkinson's disease.

In other corporate news, Bombardier (BBD-B.TO) said it has received an order for 99 Flexity Berlin trams from Berliner Verkehrsbetriebe. The order is valued at around 300 million euros, or US$431 million.

Aecon Group (ARE.TO) said its Buildings Division was awarded the $52 million construction contract for redevelopment of the Queenston-Lewiston Border Crossing Plaza in Niagara Falls by the Niagara Falls Bridge Commission.

On the commodity front, crude oil has inched above $70 per barrel in electronic trading after tumbling sharply in yesterday's deals. Gold is flat, while copper has moved up 1.2%.

There is no major economic data expected from Canada on Tuesday. Across the border, data on pending home sales, construction spending and a manufacturing survey are expected shortly after the open.

On Monday, the S&P/TSX Composite Index dropped 109.76 points or 0.99% to settle at 10,868.21. Resource stocks led the decliners.

For comments and feedback: contact editorial@rttnews.com